(1S)-Quinolactacin A1
(1S)-Quinolactacin A1 ((1S)-Quinolactacin A2) is an acetylcholinesterase inhibitor. (1S)-Quinolactacin A1 can be used in the study of Alzheimer's disease.
For research use only. We do not sell to patients.
- CAS No.: 2797139-68-3
- Formula: C16H18N2O2
- Molecular Weight:270.33
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
AChE 19.8-280 μM (IC50) |
In Vitro
(1S)-Quinolactacin A1 ((1S)-Quinolactacin A2) inhibits acetylcholinesterase with an IC50 of 19.8-280 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2797139-68-3
-
Molecular Weight 270.33
-
Formula C16H18N2O2
-
SMILES
O=C1NC([C@](C)([H])CC)C(N(C)C2=C3C=CC=C2)=C1C3=O
-
Synonyms
(1S)-Quinolactacin A2
-
Structure Classification
-
Initial Source
Penicillium citrinum
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)